Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal conditions seen in GI and primary care clinics, however physicians who treat the disease primarily rely on empirical trials of medications and their own observations and experience to manage their patients. Therefore, the American Gastroenterological Association (AGA) Institute has published evidence-based guidelines for the management and treatment of suspected GERD.

Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal conditions seen in GI and primary care clinics, however physicians who treat the disease primarily rely on empirical trials of medications and their own observations and experience to manage their patients. Therefore, the American Gastroenterological Association (AGA) Institute has published evidence-based guidelines for the management and treatment of suspected GERD.

The association between gastroesophageal reflux disease (GERD) and laryngeal disorders has been recognized since the late 1960s. Chronic laryngeal signs and symptoms associated GERD are often referred to as reflux laryngitis or laryngopharyngeal reflux (LPR). However, the cause-and-effect relationship between GERD and LPR still remains elusive.. A research article published in the World Journal of Gastroenterology addresses this question. The research team led by Dr.

The association between gastroesophageal reflux disease (GERD) and laryngeal disorders has been recognized since the late 1960s. Chronic laryngeal signs and symptoms associated GERD are often referred to as reflux laryngitis or laryngopharyngeal reflux (LPR). However, the cause-and-effect relationship between GERD and LPR still remains elusive.. A research article published in the World Journal of Gastroenterology addresses this question. The research team led by Dr.

Most people who experience chronic heartburn have symptoms that are caused by gastroesophageal reflux disease, or GERD. Two new studies presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology examined eosinophilic esophagitis (EoE), a condition that can mimic symptoms of GERD, in a small proportion of people. The first study found that the diagnosis of EoE, previously termed "allergic esophagitis," peaked during the summer months.

Most people who experience chronic heartburn have symptoms that are caused by gastroesophageal reflux disease, or GERD. Two new studies presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology examined eosinophilic esophagitis (EoE), a condition that can mimic symptoms of GERD, in a small proportion of people. The first study found that the diagnosis of EoE, previously termed "allergic esophagitis," peaked during the summer months.

Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in Orlando, Fla., demonstrated that TAK-390MR resulted in higher healing rates than lansoprazole among patients with more severe grades of erosive esophagitis (EE). TAK-390MR combines dexlansoprazole with a Dual Delayed Release? (DDR) formulation, designed to provide two separate releases of drug for extended duration of acid suppression.